Literature DB >> 14751704

Group B streptococcal disease in UK and Irish infants younger than 90 days.

Paul T Heath1, Gail Balfour, Abbie M Weisner, Androulla Efstratiou, Theresa L Lamagni, Helen Tighe, Liam A F O'Connell, Mary Cafferkey, Neville Q Verlander, Angus Nicoll, A Christine McCartney.   

Abstract

The incidence, morbidity, and mortality of group B streptococcal disease in the UK and Republic of Ireland are largely unknown. Between Feb 1, 2000, and Feb 28, 2001, we identified cases of invasive group B streptococcal disease in infants younger than 90 days through surveillance involving paediatricians, microbiologists, and parents. 568 cases were identified, equivalent to a total incidence of 0.72 per 1000 live-births (95% CI 0.66-0.78); the incidence for early-onset disease (n=377) was 0.48 per 1000 (0.43-0.53), and for late-onset disease (n=191) was 0.24 per 1000 (0.21-0.28). Risk factors were identifiable for 218 (58%) cases of early-onset disease. 53 infants died (overall 9.7%). We have established the minimum current burden of group B streptococcal disease in UK and Irish infants. This information will assist in the formulation of guidelines for prevention of this disease.

Entities:  

Mesh:

Year:  2004        PMID: 14751704     DOI: 10.1016/S0140-6736(03)15389-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  58 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Beyond counting cases: public health impacts of national Paediatric Surveillance Units.

Authors:  D Grenier; E J Elliott; Y Zurynski; R Rodrigues Pereira; M Preece; R Lynn; R von Kries; H Zimmermann; N P Dickson; D Virella
Journal:  Arch Dis Child       Date:  2006-12-11       Impact factor: 3.791

Review 3.  Interaction of neonatal phagocytes with group B streptococcus: recognition and response.

Authors:  Philipp Henneke; Reinhard Berner
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

4.  Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention.

Authors:  M Trijbels-Smeulders; G A de Jonge; P C M Pasker-de Jong; L J Gerards; A H Adriaanse; R A van Lingen; L A A Kollée
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-01-16       Impact factor: 5.747

5.  Rapid diagnosis of intrapartum group B streptococcal carriage by fluorescent in situ hybridisation.

Authors:  K A Goddard; R Townsend; E Ridgway
Journal:  J Clin Pathol       Date:  2007-07       Impact factor: 3.411

6.  Invasive group B streptococcal infection in infants in Shenzhen, China.

Authors:  Jiaosheng Zhang; Ruizhen Zhao; Yimei Dong; Yuejie Zheng
Journal:  Int J Clin Exp Med       Date:  2015-02-15

7.  Late neonatal presentation of reduced arm movement due to painful infective lymphadenopathy.

Authors:  Victoria Stokes; Caroline Fertleman
Journal:  BMJ Case Rep       Date:  2015-07-07

8.  Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.

Authors:  Clara Carreras-Abad; Madeleine Cochet; Tom Hall; Laxmee Ramkhelawon; Asma Khalil; Elisabeth Peregrine; Latha Vinayakarao; Sharmila Sivarajan; Rosol Hamid; Tim Planche; Elizabeth Sheridan; Stephen Winchester; Jane Plumb; Abdelmajid Djennad; Nick Andrews; Kirsty Le Doare; Paul Heath
Journal:  Health Technol Assess       Date:  2019-12       Impact factor: 4.014

Review 9.  Neonatal infections: group B streptococcus.

Authors:  Paul T Heath; Luke Anthony Jardine
Journal:  BMJ Clin Evid       Date:  2014-02-28

10.  Invasive group B streptococcal infection in infants, Malawi.

Authors:  Katherine J Gray; Sally L Bennett; Neil French; Amos J Phiri; Stephen M Graham
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.